Cargando…

Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications

Treatment options for chronic hepatitis C virus (HCV) infection have drastically changed since the development and licensing of new potent direct-acting antivirals (DAAs). The majority of DAAs are extensively metabolized by liver enzymes and have the ability to influence cytochrome P450 (CYP) enzyme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smolders, E. J., de Kanter, C. T. M. M., de Knegt, R. J., van der Valk, M., Drenth, J. P. H., Burger, D. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2016
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5107187/ https://www.ncbi.nlm.nih.gov/pubmed/27317413 http://dx.doi.org/10.1007/s40262-016-0407-2

Ejemplares similares

HIV/HCV Antiviral Drug Interactions in the Era of Direct-acting Antivirals
por: Rice, Donald P., et al.
Publicado: (2016)

Drug-drug interactions with direct-acting antivirals — less is more
por: Wong, Grace Lai-Hung
Publicado: (2021)

Pharmacokinetics, Efficacy, and Safety of Hepatitis C Virus Drugs in Patients with Liver and/or Renal Impairment
por: Smolders, Elise J., et al.
Publicado: (2016)

Drug Interactions with the Direct-Acting Antiviral Combination of Ombitasvir and Paritaprevir-Ritonavir
por: Badri, Prajakta S., et al.
Publicado: (2015)

Drug-drug interactions between direct-acting antivirals and statins in the treatment of chronic hepatitis C
por: Kuo, Meng-Hsuan, et al.
Publicado: (2020)

Editorial: Novel Psychoactive Drugs
por: Fattore, Liana, et al.
Publicado: (2019)

Comedications and potential drug-drug interactions with direct-acting antivirals in hepatitis C patients on hemodialysis
por: Hsu, Po-Yao, et al.
Publicado: (2021)

Drug–Drug Interactions of Newly Approved Direct-Acting Antiviral Agents in Patients with Hepatitis C
por: Gao, Lu-Hua, et al.
Publicado: (2021)

Psychoactive drugs and driving
por: Parekh, Vanita
Publicado: (2019)

Direct-Acting Antiviral Drugs and Occurrence of Hepatocellular Carcinoma: Unjust or Oppressed
por: Hassany, Sahar M, et al.
Publicado: (2020)

Review of Clinically Relevant Drug Interactions with Next Generation Hepatitis C Direct-acting Antiviral Agents
por: Hong, Jenny, et al.
Publicado: (2020)

Psychoactive Drugs and Quality of Life
por: Ventegodt, Soren, et al.
Publicado: (2003)

Psychoactive Drugs in Plastic Surgery
por: Davison, Steven P., et al.
Publicado: (2017)

Concomitant Intake of Coca‐Cola to Manage the Drug–Drug Interaction Between Velpatasvir and Omeprazole Studied in Healthy Volunteers
por: van Seyen, Minou, et al.
Publicado: (2019)

Editorial: Novel Psychoactive Drugs—The Saga Continues…
por: Weinstein, Aviv M., et al.
Publicado: (2021)

Drug–Drug Interactions between Direct Oral Anticoagulants and Hepatitis C Direct-Acting Antiviral Agents: Looking for Evidence Through a Systematic Review
por: Bellesini, Marta, et al.
Publicado: (2020)

Potential for Drug-Drug Interactions between Antiretrovirals and HCV Direct Acting Antivirals in a Large Cohort of HIV/HCV Coinfected Patients
por: Poizot-Martin, Isabelle, et al.
Publicado: (2015)

Drug-drug interactions between antithrombotics and direct-acting antivirals in hepatitis C virus (HCV) patients: A brief, updated report
por: Canonico, Mario Enrico, et al.
Publicado: (2022)

Drug Interactions in Lenacapavir-Based Long-Acting Antiviral Combinations
por: Cilento, Maria E., et al.
Publicado: (2022)

Transcriptional Effects of Psychoactive Drugs on Genes Involved in Neurogenesis
por: Bortolasci, Chiara C., et al.
Publicado: (2020)

The European Prevalence of Resistance Associated Substitutions among Direct Acting Antiviral Failures
por: Popping, Stephanie, et al.
Publicado: (2021)

Direct-Acting Antiviral Drugs Reduce Fibromyalgia Symptoms in Patients with Chronic Hepatitis C
por: Tang, Kuo-Tung, et al.
Publicado: (2022)

Adherence to Direct-Acting Antiviral Therapy in People Actively Using Drugs and Alcohol: The INCLUD Study
por: Brooks, Kristina M, et al.
Publicado: (2020)

Review article: direct‐acting antivirals for the treatment of HCV during pregnancy and lactation ‐ implications for maternal dosing, foetal exposure, and safety for mother and child
por: Freriksen, Jolien J. M., et al.
Publicado: (2019)

Direct-Acting Antiviral Drug Modulates the Mitochondrial Biogenesis in Different Tissues of Young Female Rats
por: Hafez, Hala A., et al.
Publicado: (2023)

Mental Health and economic effects: correlation between unemployment and psychoactive drugs
por: Ramos, J.
Publicado: (2022)

IDX-184 is a superior HCV direct-acting antiviral drug: a QSAR study
por: Elfiky, Abdo A., et al.
Publicado: (2016)

Late Relapse and Reinfection in HCV Patients Treated with Direct-Acting Antiviral (DAA) Drugs
por: Minosse, Claudia, et al.
Publicado: (2021)

Newborn Hearing Screening in Neonates Exposed to Psychoactive Drugs
por: Rocha, Bruna Salazar Castro da, et al.
Publicado: (2013)

The efficacy and safety of direct-acting antiviral drugs in the management of hepatitis C virus-related arthritis
por: Alian, Samah M., et al.
Publicado: (2020)

Worldwide legislative challenges related to psychoactive drugs
por: Negrei, Carolina, et al.
Publicado: (2017)

Graphene-Based Electrochemical Sensors for Psychoactive Drugs
por: Boroujerdi, Ramin, et al.
Publicado: (2022)

The next psychoactive drugs: From imipramine to ketamine
por: Carrillo, Pablo, et al.
Publicado: (2020)

Psychoactive drugs and male fertility: impacts and mechanisms
por: Hamed, Moses Agbomhere, et al.
Publicado: (2023)

Prevalence of Psychoactive Drug Use among Medical Students in a Medical College of Nepal
por: Shrestha, Jyoti Tara Manandhar, et al.
Publicado: (2020)

Psychoactive Medication and Traffic Safety
por: Verster, Joris C., et al.
Publicado: (2009)

Medications that interact with direct-acting oral anticoagulant exposure
por: de Vries, T. A. C., et al.
Publicado: (2021)

Identification of HCV Resistant Variants against Direct Acting Antivirals in Plasma and Liver of Treatment Naïve Patients
por: Raj, V. Stalin, et al.
Publicado: (2017)

Recommendations for the Management of Drug–Drug Interactions Between the COVID‐19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and Comedications
por: Marzolini, Catia, et al.
Publicado: (2022)

Fingerprinting of Psychoactive Drugs in Zebrafish Anxiety-Like Behaviors
por: Maximino, Caio, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_k721v5ma8ack0iluqrp7bodidi